Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 7Squamous Cell Carcinoma of Head and Neck 3Neuroblastoma 3Recurrence 2Neoplasms 2Melanoma 2Glioma 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Medulloblastoma 1Lymphoma 1Lung Neoplasms 1Gastrointestinal Stromal Tumors 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Carcinosarcoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Advanced or Metastatic ER+ Breast Cancer 1Adenocarcinoma of Lung 1Adenocarcinoma Of Esophagus 1

Interventions

Temozolomide 3Panobinostat 2Cyclophosphamide 2Bevacizumab 2ribociclib 1marizomib 1dipinacoline glutamate 1cemiplimab 1Topotecan 1TIC10 compound 1Re-Irradiation 1Radiotherapy 1Radiation 1Maintenance 1Irinotecan 1Imiquimod 1Granulocyte-Macrophage Colony-Stimulating Factor 1Erlotinib Hydrochloride 1Drug Tolerance 1Doxorubicin 1Diphtheria-Tetanus Vaccine 1Congresses as Topic 1Cilengitide 1Cetuximab 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Diffuse Intrinsic Pontine Glioma × ribociclib × Clear all
NCT02607124 2020-11-05

A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy

Children's Hospital Medical Center, Cincinnati

Phase 1/2 Terminated
11 enrolled 10 charts
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡